MRKR
Price
$2.76
Change
-$0.14 (-4.83%)
Updated
Nov 30, 6:59 PM EST
SRNEQ
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Feb 22, 6:59 PM EST
90 days until earnings call
Ad is loading...

Compare trend and price MRKR vs SRNEQ

Header iconMRKR vs SRNEQ Comparison
Open Charts MRKR vs SRNEQBanner chart's image
Marker Therapeutics
Price$2.76
Change-$0.14 (-4.83%)
Volume$13.51K
CapitalizationN/A
Sorrento Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$77.42M
CapitalizationN/A
View a ticker or compare two or three
MRKR vs SRNEQ Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
MRKR vs. SRNEQ commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRKR is a StrongBuy and SRNEQ is a Sell.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (MRKR: $2.76 vs. SRNEQ: $0.05)
Brand notoriety: MRKR: Not notable vs. SRNEQ: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRKR: 55% vs. SRNEQ: 76%
Market capitalization -- MRKR: $24M vs. SRNEQ: $179.17M
MRKR [@Biotechnology] is valued at $24M. SRNEQ’s [@Biotechnology] market capitalization is $179.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRKR’s FA Score shows that 1 FA rating(s) are green whileSRNEQ’s FA Score has 1 green FA rating(s).

  • MRKR’s FA Score: 1 green, 4 red.
  • SRNEQ’s FA Score: 1 green, 4 red.
According to our system of comparison, SRNEQ is a better buy in the long-term than MRKR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRKR’s TA Score shows that 5 TA indicator(s) are bullish while SRNEQ’s TA Score has 4 bullish TA indicator(s).

  • MRKR’s TA Score: 5 bullish, 2 bearish.
  • SRNEQ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MRKR is a better buy in the short-term than SRNEQ.

Price Growth

MRKR (@Biotechnology) experienced а +2.99% price change this week, while SRNEQ (@Biotechnology) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.25%. For the same industry, the average monthly price growth was +26.80%, and the average quarterly price growth was +20.14%.

Reported Earning Dates

MRKR is expected to report earnings on May 11, 2023.

SRNEQ is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+2.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MRKR with price predictions.
OPEN
A.I.dvisor published
a Summary for SRNEQ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SRNEQ($179M) has a higher market cap than MRKR($24M). MRKR YTD gains are higher at: 3.799 vs. SRNEQ (-94.684). MRKR has higher annual earnings (EBITDA): -24.84M vs. SRNEQ (-645.56M). SRNEQ has more cash in the bank: 50.3M vs. MRKR (17.5M). MRKR has less debt than SRNEQ: MRKR (0) vs SRNEQ (170M). SRNEQ has higher revenues than MRKR: SRNEQ (60.7M) vs MRKR (9.01M).
MRKRSRNEQMRKR / SRNEQ
Capitalization24M179M13%
EBITDA-24.84M-645.56M4%
Gain YTD3.799-94.684-4%
P/E RatioN/AN/A-
Revenue9.01M60.7M15%
Total Cash17.5M50.3M35%
Total Debt0170M-
FUNDAMENTALS RATINGS
MRKR vs SRNEQ: Fundamental Ratings
MRKR
SRNEQ
OUTLOOK RATING
1..100
1850
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5397
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRNEQ's Valuation (27) in the Biotechnology industry is in the same range as MRKR (30) in the Other Consumer Services industry. This means that SRNEQ’s stock grew similarly to MRKR’s over the last 12 months.

SRNEQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MRKR (100) in the Other Consumer Services industry. This means that SRNEQ’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's SMR Rating (97) in the Other Consumer Services industry is in the same range as SRNEQ (100) in the Biotechnology industry. This means that MRKR’s stock grew similarly to SRNEQ’s over the last 12 months.

MRKR's Price Growth Rating (53) in the Other Consumer Services industry is somewhat better than the same rating for SRNEQ (97) in the Biotechnology industry. This means that MRKR’s stock grew somewhat faster than SRNEQ’s over the last 12 months.

MRKR's P/E Growth Rating (100) in the Other Consumer Services industry is in the same range as SRNEQ (100) in the Biotechnology industry. This means that MRKR’s stock grew similarly to SRNEQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKRSRNEQ
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGRNQ0.26N/A
N/A
Capstone Green Energy Corporation
GELYF1.13N/A
N/A
Geely Automobile Holdings Ltd.
KHNGY58.51N/A
N/A
Kuehne & Nagel International AG
NILIF0.35N/A
N/A
Surge Battery Metals
PETRY9.11N/A
N/A
Vibra Energia SA

MRKR and

Correlation & Price change

A.I.dvisor tells us that MRKR and SRNEQ have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and SRNEQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
-4.83%
SRNEQ - MRKR
27%
Poorly correlated
N/A
FATE - MRKR
27%
Poorly correlated
-4.96%
SNPX - MRKR
27%
Poorly correlated
+0.04%
SRRK - MRKR
26%
Poorly correlated
+4.14%
MDGL - MRKR
25%
Poorly correlated
+3.01%
More

SRNEQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRNEQ has been closely correlated with SGMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SRNEQ jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRNEQ
1D Price
Change %
SRNEQ100%
N/A
SGMO - SRNEQ
73%
Closely correlated
+4.57%
GTHX - SRNEQ
64%
Loosely correlated
+10.59%
AGEN - SRNEQ
63%
Loosely correlated
+10.92%
CHRS - SRNEQ
60%
Loosely correlated
-2.06%
TECH - SRNEQ
57%
Loosely correlated
-0.35%
More